Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

14.16
+0.05000.35%
Volume:176.11K
Turnover:2.47M
Market Cap:1.31B
PE:-13.46
High:14.40
Open:13.96
Low:13.65
Close:14.11
52wk High:15.10
52wk Low:3.35
Shares:92.33M
Float Shares:63.79M
Volume Ratio:0.77
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0517
EPS(LYR):-0.5300
ROE:-141.68%
ROA:-25.71%
PB:29.68
PE(LYR):-26.72

Loading ...

Alpha Tau reports 100% local disease control in pooled Alpha DaRT pancreatic trials

Reuters
·
May 04

BRIEF-Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing

Reuters
·
Apr 28

Alpha Tau files $300M mixed securities shelf

TIPRANKS
·
Apr 28

Alpha Tau Medical Ltd - May Sell up to $100 Mln Ordinary Shares Under Equity Distribution Agreement - SEC Filing

THOMSON REUTERS
·
Apr 28

Alpha Tau pancreatic cancer Alpha DaRT pooled data accepted for ASCO presentation

Reuters
·
Apr 27

Alpha Tau says FDA approves IDE supplement expanding pancreatic cancer IMPACT trial

Reuters
·
Apr 23

Alpha Tau Announces FDA Approval of Ide Supplement to Expand Alpha Dart® Impact Trial to Patients With Pancreatic Cancer Receiving Gemcitabine With Abraxane® (Nab-Paclitaxel)

THOMSON REUTERS
·
Apr 23

Alpha Tau Medical Ltd - Impact Trial Expanded to Recruit Total of 40 Patients

THOMSON REUTERS
·
Apr 23

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe With Alpha Dart® in French Multicenter Acapella Clinical Trial

THOMSON REUTERS
·
Apr 23

BRIEF-Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026

Reuters
·
Mar 31

Alpha Tau Medical Ltd. files initial beneficial ownership statement for Director Nadav Kidron

Reuters
·
Mar 19

Alpha Tau Medical Director Samuel Morry Blumenfeld Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. Director David Mark Milch Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. Director Maya Netser Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. files Form 3 initial beneficial ownership statement for CFO Raphi Levy

Reuters
·
Mar 19

Alpha Tau CFO Raphi Levy to present at Sidoti Virtual Small Cap Conference

Reuters
·
Mar 16

Alpha Tau price target raised to $9 from $7 at Citi

TIPRANKS
·
Mar 11

Alpha Tau Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 11

Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses

TIPRANKS
·
Mar 11

Alpha Tau Medical Q4 EPS $(0.14) Misses $(0.12) Estimate

Benzinga Earnings
·
Mar 10